Previous 10 | Next 10 |
Based on FDA feedback, Adamis Pharmaceuticals ( ADMP -4.5% ) has removed kaléo's EVZIO (naloxone HCl injection) 2 mg auto-injector as the Reference Listed Drug (RLD) in its marketing application seeking approval for its higher dose naloxone injection product for the emergency trea...
SAN DIEGO, June 11, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the receipt of Adamis’ amendment to its previously submitted New Drug Application (NDA) for its higher...
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that management is scheduled to present a company overview at two upcoming conferences in June 2019. During the conferences, management from Adamis will discuss the compan...
Gainers: CIRCOR International, Inc. (NYSE: CIR ) +41% . JMU Limited (NASDAQ: JMU ) +39% . Westwater Resources, Inc. (NASDAQ: WWR ) +21% . Biocept, Inc. (NASDAQ: BIOC ) +22% . Sesen Bio, Inc. (NASDAQ: SESN ) +21% . OncoSec Medical Incorporated (NASDAQ: ONCS ) +20% . Dycom Indust...
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that on May 20, 2019, it received notice that it had been named and served as a defendant in a lawsuit filed by kaléo Inc. in the United States District Court for the Dist...
Since my last Adamis Pharmaceutical ( ADMP ) article, the company has reported their first-quarter revenue that revealed the first ever Symjepi revenues. Perhaps the most surprising development was that the company also held an earnings call...perhaps they have been listening? Overall, the com...
Gainers: Can-Fite BioPharma (NYSEMKT: CANF ) +38% . Outlook Therapeutics (NASDAQ: OTLK ) +30% . Del Frisco's Restaurant Group (NASDAQ: DFRG ) +27% . Orion Energy Systems (NASDAQ: OESX ) +23% . Sprint Corporation (NYSE: S ) +22% . ENDRA Life Sciences (NASDAQ: NDRA ) +18% . Sesen...
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the company’s high dose naloxone product candidate. The notification...
Adamis Pharmaceuticals Corporation (ADMP) Q1 2019 Results Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Dennis Carlo – President and Chief Executive Officer Rob Hopkins – Chief Financial Officer Ronald Moss – Chief Medical Officer Dav...
Adamis Pharmaceuticals (NASDAQ: ADMP ): Q1 GAAP EPS of -$0.19 misses by $0.02 . Revenue of $4.9M (+53.1% Y/Y) misses by $0.89M . Shares -1.8% . Press Release More news on: Adamis Pharmaceuticals Corporation, Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...